Gastroenterologist Dr. Adam Elfant discusses the current CRC screening paradigm and introduces the clinical development and testing process of Cologuard, a noninvasive stool DNA-based test approved by the FDA for CRC screening in the average risk population.
Adam Elfant, MD
Associate Professor of Medicine
Division of Gastroenterology and Liver Disease
Cooper Medical School at Rowan University
Mt Laurel, NJ